Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD
NCT01213667
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
110
Enrollment
OTHER
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Ranibizumab
Sponsor
University of Cologne